Immu-132, A Potential New Antibody-Drug Conjugate (Adc) For The Treatment Of Triple-Negative Breast Cancer (Tnbc): Preclinical And Initial Clinical Results

CANCER RESEARCH(2015)

引用 1|浏览19
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要